Reply to Abildgaard et al.: lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA<sub>1c</sub> POCT instrument in a true clinical setting-Reference-Cited by-同舟云学术

Reply to Abildgaard et al.: lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA_1c POCT instrument in a true clinical setting

Published:2022-10-18 Issue:1 Volume:61 Page:e5-e7
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Mayfield Jeff¹,Samoszuk Michael¹

Affiliation:

1. Siemens Healthineers USA , Malvern , USA

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2022-0835/pdf

Reference10 articles.

1. Abildgaard, A, Knudsen, CS, Bjerg, LN, Lund, S, Støy, J. Lot variation and inter-device differences contribute to poor analytical performance of the DCA vantage™ HbA1c POCT instrument in a true clinical setting. Clin Chem Lab Med 2021;60:127–34. https://doi.org/10.1515/cclm-2021-0720.

2. Kallner, A, Theodorsson, E. Repeatability imprecision from analysis of duplicates of patient samples and control materials. Scand J Clin Lab Invest 2020;80:210–4. https://doi.org/10.1080/00365513.2019.1710243.

3. Dubach, IL, Christ, ER, Diem, P. HbA1c-testing: evaluation of two point-of-care analysers. Prim Care Diabetes 2019;13:583–7. https://doi.org/10.1016/j.pcd.2019.05.007.

4. Petersen, JR, Omoruyi, FO, Mohammad, AA, Shea, TJ, Okorodudu, AO, Ju, H. Hemoglobin A1c: assessment of three POC analyzers relative to a central laboratory method. Clin Chim Acta 2010;411:2062–6. https://doi.org/10.1016/j.cca.2010.09.004.

5. Szymezak, J, Leroy, N, Lavalard, E, Gillery, P. Evaluation of the DCA vantage analyzer for HbA 1c assay. Clin Chem Lab Med 2008;46:1195–8. https://doi.org/10.1515/CCLM.2008.228.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to letter from Mayfield et al. regarding “Lot variation and inter-device differences contribute to poor analytical performance of the DCA Vantage™ HbA_1c POCT instrument in a true clinical setting”;Clinical Chemistry and Laboratory Medicine (CCLM);2022-10-26